|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with TNF-α x VEGF x IGF-2R
100 Translational Medicine associated with TNF-α x VEGF x IGF-2R
0 Patents (Medical) associated with TNF-α x VEGF x IGF-2R